Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Brachytherapy|September 12, 2016
Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancerSungjae Baek, Fumiaki Isohashi, Hiroko Yamaguchi, et al.
The American Journal of Pathology|January 23, 2016
Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic CellsAska Toda, Kenjiro Sawada, Tomoyuki Fujikawa, et al.
Journal of Radiation Research|January 24, 2015
Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rateNaoyuki Kanayama, Fumiaki Isohashi, Yasuo Yoshioka, et al.
Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
The American Journal of Pathology|March 19, 2013
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expressionChifumi Ohyagi-Hara, Kenjiro Sawada, Shoji Kamiura, et al.
Journal of the National Cancer Institute|June 21, 2014
Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant featureSeiji Mabuchi, Yuri Matsumoto, Mahiru Kawano, et al.
Obstetrics and Gynecology|May 3, 2014
Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancerKoji Matsuo, Kiyoshi Yoshino, Kosuke Hiramatsu, et al.
Pageof 19